Comparing the clinical and cost-effectiveness of COlesevelam for Bile Acid diarrhoea with colestyramine or Loperamide, including long Term follow-up (COBALT).
National Institute for Health and Care Research
· United Kingdom · £186.98M GBP
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.